Arthur Przybyl Insider Profile
11 Followers
Arthur Przybyl, President & CEO, Director at ANI Pharmaceuticals, holds 190.31K shares in ANI Pharmaceuticals (Ticker: ANIP), holds 239.82K shares in Akorn (Ticker: AKRXQ).
Arthur Przybyl's Trading History
| ANIPANI Pharmaceuticals | Apr 08, 2020 | President & CEO, Director | Uninformative Sell | 234.76K | $13.49M | |
| AKRXQAkorn | Jan 02, 2009 | ― | Informative Sell | 1.47M | $6.48K |
You May Also Like
Arthur Przybyl insider profile FAQ
What is the percentage of profitable transactions made by Arthur Przybyl?
The percentage of profitable transactions made by Arthur Przybyl is 70%.
What is the average return per transaction made by Arthur Przybyl?
The average return per transaction made by Arthur Przybyl is 36.10%.
What stocks does Arthur Przybyl hold?
Arthur Przybyl holds: ANIP, AKRXQ stocks.
What was Arthur Przybyl’s latest transaction?
Arthur Przybyl’s latest transaction was an Uninformative Sell of $234.76K.
What was Arthur Przybyl's most profitable transaction?
Arthur Przybyl’s most profitable transaction was an Informative Buy of ANIP stock on September 9, 2014. The return on the trade was 139.80%.
What is Arthur Przybyl's role in ANI Pharmaceuticals?
Arthur Przybyl's role in ANI Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
